AcelRx Pharmaceuticals (ACRX) PT Lowered to $4 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on AcelRx Pharmaceuticals (NASDAQ: ACRX) to $4.00 (from $9.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
